z-logo
Premium
Defining the clinical phenotype of COVID‐19 in children
Author(s) -
Giacomet Vania,
Stracuzzi Marta,
Paradiso Laura,
Di Cosimo Maria Elisabetta,
Rubinacci Valeria,
Zuccotti GianVincenzo
Publication year - 2020
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.13355
Subject(s) - medicine , covid-19 , phenotype , betacoronavirus , coronavirus infections , medline , pandemic , virology , genetics , outbreak , infectious disease (medical specialty) , gene , disease , biology , political science , law
On January 7, 2020, a novel coronavirus (SARS‐CoV‐2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS‐CoV‐2 discovery, the corresponding disease (COVID‐19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID‐19 had been confirmed worldwide, with more than 318.599 deaths.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here